Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stefan G. Hofmann is active.

Publication


Featured researches published by Stefan G. Hofmann.


Depression and Anxiety | 2012

Emotion dysregulation model of mood and anxiety disorders.

Stefan G. Hofmann; Alice T. Sawyer; Angela Fang; Anu Asnaani

In this review, we present a transdiagnostic emotion dysregulation model of mood and anxiety disorders. This model posits that a triggering event, in conjunction with an existing diathesis, leads to negative or positive affect, depending on the persons affective style. Mood and anxiety disorders are the result of emotion dysregulation of negative affect, coupled with deficiencies in positive affect. The theoretical background of the model is discussed and a range of clinical applications of the model is described.


Depression and Anxiety | 2010

Cultural aspects in social anxiety and social anxiety disorder

Stefan G. Hofmann; Anu Asnaani; Devon E. Hinton

To examine cultural aspects in social anxiety and social anxiety disorder (SAD), we reviewed the literature on the prevalence rates, expressions, and treatments of social anxiety/SAD as they relate to culture, race, and ethnicity. We further reviewed factors that contribute to the differences in social anxiety/SAD between different cultures, including individualism/collectivism, perception of social norms, self‐construal, gender roles, and gender role identification. Our review suggests that the prevalence and expression of social anxiety/SAD depends on the particular culture. Asian cultures typically show the lowest rates, whereas Russian and US samples show the highest rates, of SAD. Taijin kyofusho is discussed as a possible culture‐specific expression of social anxiety, although the empirical evidence concerning the validity of this syndrome has been mixed. It is concluded that the individuals social concerns need to be examined in the context of the persons cultural, racial, and ethnic background in order to adequately assess the degree and expression of social anxiety and SAD. This has direct relevance for the upcoming DSM‐V. Depression and Anxiety, 2010.


Depression and Anxiety | 2010

Culture and the anxiety disorders: recommendations for DSM-V.

Roberto Lewis-Fernández; Devon E. Hinton; Amaro J. Laria; Elissa H. Patterson; Stefan G. Hofmann; Michelle G. Craske; Dan J. Stein; Anu Asnaani; B A Betty Liao

Background: The anxiety disorders specified in the fourth edition, text revision, of The Diagnostic and Statistical Manual (DSM‐IV‐TR) are identified universally in human societies, and also show substantial cultural particularities in prevalence and symptomatology. Possible explanations for the observed epidemiological variability include lack of measurement equivalence, true differences in prevalence, and limited validity or precision of diagnostic criteria. One central question is whether, through inadvertent “over‐specification” of disorders, the post‐DSM‐III nosology has missed related but somewhat different presentations of the same disorder because they do not exactly fit specified criteria sets. This review canvases the mental health literature for evidence of cross‐cultural limitations in DSM‐IV‐TR anxiety disorder criteria. Methods: Searches were conducted of the mental health literature, particularly since 1994, regarding cultural or race/ethnicity‐related factors that might limit the universal applicability of the diagnostic criteria for six anxiety disorders. Results: Possible mismatches between the DSM criteria and the local phenomenology of the disorder in specific cultural contexts were found for three anxiety disorders in particular. These involve the unexpectedness and 10‐minute crescendo criteria in Panic Disorder; the definition of social anxiety and social reference group in Social Anxiety Disorder; and the priority given to psychological symptoms of worry in Generalized Anxiety Disorder. Limited evidence was found throughout, particularly in terms of neurobiological markers, genetic risk factors, treatment response, and other DSM‐V validators that could help clarify the cross‐cultural applicability of criteria. Conclusions: On the basis of the available data, options and preliminary recommendations for DSM‐V are put forth that should be further evaluated and tested. Depression and Anxiety, 2010© 2009 Wiley‐Liss, Inc.


Depression and Anxiety | 1999

Subtypes of social phobia in adolescents.

Stefan G. Hofmann; Anne Marie Albano; Richard G. Heimberg; Susan Tracey; Bruce F. Chorpita; David H. Barlow

Thirty‐three social phobic adolescents were asked to name their ten most feared social situations. Two independent judges classified each situation reported by the participants into one of four situational domains: formal speaking/interactions, informal speaking/interactions, observation by others, and assertion. Fifteen participants (45.5%) were assigned a generalized subtype of social phobia because they endorsed at least moderate anxiety in all four situational domains. This subgroup scored higher on self‐report measures of anxiety and depression than the rest of the sample. These results provide empirical support for the existence of subtypes of social phobia in adolescents. Depression and Anxiety 9:15–18, 1999.


Depression and Anxiety | 2014

Social anxiety disorder in DSM-5

Richard G. Heimberg; Stefan G. Hofmann; Michael R. Liebowitz; Franklin R. Schneier; Jasper A. J. Smits; Murray B. Stein; Devon E. Hinton; Michelle G. Craske

With the publication of DSM‐5, the diagnostic criteria for social anxiety disorder (SAD, also known as social phobia) have undergone several changes, which have important conceptual and clinical implications. In this paper, we first provide a brief history of the diagnosis. We then review a number of these changes, including (1) the primary name of the disorder, (2) the increased emphasis on fear of negative evaluation, (3) the importance of sociocultural context in determining whether an anxious response to a social situation is out of proportion to the actual threat, (4) the diagnosis of SAD in the context of a medical condition, and (5) the way in which we think about variations in the presentation of SAD (the specifier issue). We then consider the clinical implications of changes in DSM‐5 related to these issues.


Depression and Anxiety | 2014

GLUCOCORTICOIDS ENHANCE IN VIVO EXPOSURE-BASED THERAPY OF SPIDER PHOBIA

Leila M. Soravia; Markus Heinrichs; Livia Winzeler; Melanie Fisler; Wolfgang Schmitt; Helge Horn; Thomas Dierks; Werner Strik; Stefan G. Hofmann; Dominique J.-F. de Quervain

Preclinical and clinical studies indicate that the administration of glucocorticoids may promote fear extinction processes. In particular, it has been shown that glucocorticoids enhance virtual reality based exposure therapy of fear of heights. Here, we investigate whether glucocorticoids enhance the outcome of in vivo exposure‐based group therapy of spider phobia.


Depression and Anxiety | 1998

Effects of panic disorder treatments on personality disorder characteristics

Stefan G. Hofmann; M. Katherine Shear; David H. Barlow; Jack M. Gorman; B A David Hershberger; Marcus Patterson; Scott W. Woods

Ninety‐three patients with panic disorder and mild or no agoraphobia were treated for their panic disorder by using either 11 sessions of individual cognitive‐behavior therapy or imipramine. Before and after treatment, their panic disorder symptomatology was assessed, and a self‐report measure was administered to measure personality disorder characteristics [Klein et al., 1990: Wisconsin Personality Disorders Inventory]. In addition, some patients received this personality assessment again after six monthly maintenance sessions. Both treatments were equally effective in reducing panic disorder symptomatology, and both treatments had a positive influence on personality disorder characteristics. Personality disorder characteristics did not predict treatment outcome in either group. The implications of the findings for the assessment of personality and the treatment of panic disorder are discussed. Depression and Anxiety 8:14–20, 1998.


Depression and Anxiety | 2012

Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD

Devon E. Hinton; A B A Maria Kredlow; Eric Bui; Mark H. Pollack; Stefan G. Hofmann

There is only one previously published study of treatment change across initial pharmacological treatment for a minority or refugee group with posttraumatic stress disorder (PTSD). That study found that certain somatic symptoms among Southeast Asian populations did not improve across treatment. This article assesses in a culturally sensitive way symptom change through time of Cambodian patients presenting for pharmacotherapy treatment of PTSD.


Depression and Anxiety | 2013

Sleep quality predicts treatment outcome in CBT for social anxiety disorder.

Alyson K. Zalta; Sheila M. Dowd; David Rosenfield; Jasper A. J. Smits; Michael W. Otto; Naomi M. Simon; Alicia E. Meuret; Luana Marques; Stefan G. Hofmann; Mark H. Pollack

Sleep quality may be an important, yet relatively neglected, predictor of treatment outcome in cognitive‐behavioral therapy (CBT) for anxiety disorders. Specifically, poor sleep quality may impair memory consolidation of in‐session extinction learning. We therefore examined sleep quality as a predictor of treatment outcome in CBT for social anxiety disorder and the impact of d‐cycloserine (DCS) on this relationship.


Depression and Anxiety | 2004

Scoring error of social avoidance and distress scale and its psychometric implications

Stefan G. Hofmann; Patricia Marten DiBartolo; Robert M. Holaway; Richard G. Heimberg

Collaboration


Dive into the Stefan G. Hofmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jasper A. J. Smits

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alicia E. Meuret

Southern Methodist University

View shared research outputs
Top Co-Authors

Avatar

Alyson K. Zalta

Rush University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge